Axorus is a French company that develops a High Acuity Artificial Retina for patients suffering from AMD (Age-Related Macular Degeneration) and Retinitis Pigmentosa.
With our partners at Boston University, we developed a high resolution neurostimulator, using patented photoacoustic technology.
Beyond the retina, our goal is to build bridges between the nervous system and electronic devices or medical implants. We will use our technologies to develop a wide range of medical implants to treat the symptoms
of neurodegenerative diseases and enhance the quality of life.
Our vision is to become an originator of a new neurotech industry that makes it possible for
people to buy spare parts to recover their lost capabilities.
Team
Jean-Damien
CEO
Hélène, PhD
CTO
Yueming, PhD
Scientist
Julien
Material Engineer
Anna
Material Engineer
Scientific Advisors
Dr. Serge Picaud
Vision Institute Director
Pr. Ji-Xin Cheng
Photoacoustic Scientist
Pr. Chen Yang
Photoacoustic Scientist
Dr. Vasily Smirnov
Neuro-ophthalmologist
Partners
Product
Bionic Retina
We are developing an Artificial Retina aimed at restoring sight for people with
damaged retinas.
This medical implant is suitable for people who have damaged photoreceptors (cones and rods) but
otherwise functioning retinas, as is the case for many patients suffering from Retinitis
Pigmentosa (RP) or advanced dry Age-related Macular Degeneration (AMD).
The implant will be inserted subretinally, where photoreceptors are located in a healthy retina. The
artificial retina acts as a substitute for the damaged photoreceptors by converting
light into a signal the brain can interpret.
Tech
We are using genetic-free photoacoustic neuromodulation to stimulate single cells inside the retina in order to provide a high acuity for the patients.
Devenez actionnaire d'Axorus :